Literature DB >> 20528874

Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party.

Judith Marsh, Gerard Socie, Andre Tichelli, Hubert Schrezenmeier, Britta Hochsmann, Antonio M Risitano, Monika Fuehrer, Albert N Bekassy, Elizabeth T Korthof, Anna Locasciulli, Per Ljungman, Andrea Bacigalupo, Bruce Camitta, Neal S Young, Jakob Passweg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20528874      PMCID: PMC3521531          DOI: 10.1111/j.1365-2141.2010.08200.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  9 in total

1.  Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia.

Authors:  G J Laundy; B A Bradley; B M Rees; M Younie; J M Hows
Journal:  Transfusion       Date:  2004-06       Impact factor: 3.157

2.  Pilot study of HLA alloimmunization after transfusion with pre-storage leucodepleted blood products in aplastic anaemia.

Authors:  S B Killick; N Win; J C Marsh; T Kaye; A Yandle; C Humphries; S M Knowles; E C Gordon-Smith
Journal:  Br J Haematol       Date:  1997-06       Impact factor: 6.998

Review 3.  Guidelines for the diagnosis and management of aplastic anaemia.

Authors:  Judith C W Marsh; Sarah E Ball; Jamie Cavenagh; Phil Darbyshire; Inderjeet Dokal; Edward C Gordon-Smith; Jane Keidan; Andrew Laurie; Anna Martin; Jane Mercieca; Sally B Killick; Rhona Stewart; John A L Yin
Journal:  Br J Haematol       Date:  2009-08-10       Impact factor: 6.998

4.  Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force.

Authors: 
Journal:  Transfus Med       Date:  1996-09       Impact factor: 2.019

5.  Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia.

Authors:  Phillip Scheinberg; Steven H Fischer; Li Li; Olga Nunez; Colin O Wu; Elaine M Sloand; Jeffrey I Cohen; Neal S Young; A John Barrett
Journal:  Blood       Date:  2006-12-05       Impact factor: 22.113

6.  Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.

Authors: 
Journal:  N Engl J Med       Date:  1997-12-25       Impact factor: 91.245

7.  Gamma-irradiation of pretransplant blood transfusions from unrelated donors prevents sensitization to minor histocompatibility antigens on dog leukocyte antigen-identical canine marrow grafts.

Authors:  M A Bean; T Graham; F R Appelbaum; H J Deeg; F Schuening; G E Sale; R Storb
Journal:  Transplantation       Date:  1994-02       Impact factor: 4.939

8.  The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease.

Authors:  Lorna M Williamson; Dorothy Stainsby; Hilary Jones; Elizabeth Love; Catherine E Chapman; Cristina Navarrete; Geoff Lucas; Cynthia Beatty; Angela Casbard; Hannah Cohen
Journal:  Transfusion       Date:  2007-08       Impact factor: 3.157

9.  Transfusion-associated graft-versus-host disease in immunocompetent patients: case series and review of the literature.

Authors:  Kemal Agbaht; Neriman Defne Altintas; Arzu Topeli; Ozay Gokoz; Osman Ozcebe
Journal:  Transfusion       Date:  2007-08       Impact factor: 3.157

  9 in total
  5 in total

Review 1.  How I treat acquired aplastic anemia.

Authors:  Phillip Scheinberg; Neal S Young
Journal:  Blood       Date:  2012-04-19       Impact factor: 22.113

Review 2.  Clinical management of aplastic anemia.

Authors:  Amy E Dezern; Robert A Brodsky
Journal:  Expert Rev Hematol       Date:  2011-04       Impact factor: 2.929

Review 3.  New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia.

Authors:  Wendy Weston; Vineet Gupta; Rebecca Adkins; Roland Jurecic
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

Review 4.  Acquired aplastic anemia in children.

Authors:  Helge D Hartung; Timothy S Olson; Monica Bessler
Journal:  Pediatr Clin North Am       Date:  2013-10-16       Impact factor: 3.278

Review 5.  Aplastic anemia in adolescents and young adults.

Authors:  Amy E DeZern; Eva C Guinan
Journal:  Acta Haematol       Date:  2014-09-10       Impact factor: 2.195

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.